Cisplatin-induced psoriasiform eruption.

Oulad Ali, Sara; Belcadi, Jihane; El Ouarith, Ihssane; Znati, Kaoutar; El Baz, Salma; Meziane, Mariame; Senouci, Karima

Oulad Ali, Sara; Belcadi, Jihane; El Ouarith, Ihssane; Znati, Kaoutar; El Baz, Salma; Meziane, Mariame; Senouci, Karima.

Afiliação

Oulad Ali S; Department of Dermatology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco.
Belcadi J; Department of Dermatology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco.
El Ouarith I; Department of Histopathology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco.
Znati K; Department of Histopathology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco.
El Baz S; Department of Radiotherapy, Mohamed V University in Rabat, National Institute of Oncology, Rabat, Morocco.
Meziane M; Department of Dermatology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco.
Senouci K; Department of Dermatology, Mohammed V University in Rabat, Ibn Sina University Hospital, Rabat, Morocco.

Dermatol Ther ; 35(12): e15921, 2022 12.

Article em En | MEDLINE | ID: mdl-36219524

Assuntos

Toxidermias; Exantema; Psoríase; Humanos; Cisplatino/efeitos adversos; Psoríase/induzido quimicamente; Psoríase/diagnóstico; Psoríase/tratamento farmacológico; Toxidermias/diagnóstico; Toxidermias/etiologia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Toxidermias / Exantema Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Marrocos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google